A Pennsylvania state court judge last week overturned part of a jury verdict that gave Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon its first win in five pelvic mesh trials in Philadelphia.
Last month a jury in the Philadelphia Court of Common Pleas cleared Ethicon in the fourth pelvic mesh bellwether to go to trial there, despite finding that the company’s TVT-Secur product was defectively designed and that Ethicon failed to warn of its risks.
Kimberly Adkins had sued in 2013, alleging that the TVT-Secur mesh she was implanted with in July 2010 to treat urinary incontinence caused her injuries.
